Deep Genomics

Deep Genomics is in the field of drug discovery and development using AI to identify novel targets for therapeutic intervention.

Deep Genomics develops RNA-based therapies using artificial intelligence. Their AI platform analyzes genomic data to identify therapeutic targets and design drug candidates for genetic diseases. The company focuses on treating metabolic disorders and neurological conditions. Their proprietary technology, including the AI Workbench and BigRNA foundation model, enables efficient discovery of novel biological mechanisms and potential treatments that traditional methods might miss.